Zac Miklja
Credentials: ·
History
- 2018–2022
Doctor of Medicine
Research
Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma
Journal of Clinical Investigation · 2020 · First of 33 authors · 64 citations
Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations
Neuro-Oncology · 2019 · First of 22 authors · 62 citations
Cell Reports · 2022 · 59 citations
- CK
6 papers
4 papers
3 papers · 3 as a resident
3 papers · 3 as a resident
- PR
3 papers
3 papers
- RS
3 papers
3 papers
